U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191221191221Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNo Results AvailableAcute Myelogenous LeukemiaDrug: clofarabine (IV formulation)https://ClinicalTrials.gov/show/NCT00044889
191222191222Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor AntagonistCompletedNo Results AvailableLeiomyomaDrug: CDB-2914https://ClinicalTrials.gov/show/NCT00044876
191223191223Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal CarcinomaCompletedNo Results AvailableColorectal Neoplasms|Metastases, NeoplasmBiological: Erbitux (Cetuximab)https://ClinicalTrials.gov/show/NCT00044863
191224191224Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal WomenTerminatedNo Results AvailableHIV InfectionsDrug: Medroxyprogesterone acetate|Drug: Estradiolhttps://ClinicalTrials.gov/show/NCT00044837
191225191225Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNo Results AvailableAsthmaDrug: Fexofenadinehttps://ClinicalTrials.gov/show/NCT00044824
191226191226Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCompletedNo Results AvailableAsthmaDrug: Fexofenadinehttps://ClinicalTrials.gov/show/NCT00044811
191227191227Magnetic Stimulation Therapy for Treating Vascular DepressionCompletedNo Results AvailableDepressive Disorder|DepressionProcedure: Repetitive transcranial magnetic stimulation (rTMS)|Drug: Citalopram|Procedure: Sham rTMShttps://ClinicalTrials.gov/show/NCT00044798
191228191228Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid TumorsTerminatedNo Results AvailableSolid TumorsDrug: triacetyluridine|Drug: fluorouracil|Drug: leucovorin|Drug: camptosarhttps://ClinicalTrials.gov/show/NCT00044785
191229191229Study Evaluating Venlafaxine ER in Patients With Panic DisorderCompletedNo Results AvailablePanic DisorderDrug: Venlafaxine ERhttps://ClinicalTrials.gov/show/NCT00044772
191230191230Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or LymphomaCompletedNo Results AvailableHematologic NeoplasmsDrug: Piperacillin/Tazobactam (Tazocin)https://ClinicalTrials.gov/show/NCT00044759
191231191231Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot InfectionsCompletedNo Results AvailableDiabetes Mellitus|Diabetic FootDrug: Piperacillin/Tazobactamhttps://ClinicalTrials.gov/show/NCT00044746
191232191232Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell TransplantCompletedNo Results AvailableAcute Myelogenous LeukemiaDrug: Mylotarg (gemtuzumab ozogamicin) Injectionhttps://ClinicalTrials.gov/show/NCT00044733
191233191233Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNo Results AvailableChronic Kidney Failure|Graft vs Host Disease|Kidney TransplantationDrug: Rapamunehttps://ClinicalTrials.gov/show/NCT00044720
191234191234Evaluation of an Orally Administered Medication When Taken in Conjunction With PramlintideCompletedNo Results AvailableDiabetes Mellitus, Non-Insulin-DependentDrug: Pramlintide acetatehttps://ClinicalTrials.gov/show/NCT00044707
191235191235Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Non-Insulin-DependentDrug: Placebo 0.01 mL|Drug: Placebo 0.02 mL|Drug: Placebo 0.03 mL|Drug: Placebo 0.04 mL|Drug: AC2993 2.5 mcg|Drug: AC2993 5.0 mcg|Drug: AC2993 7.5 mcg|Drug: AC2993 10.0 mcghttps://ClinicalTrials.gov/show/NCT00044694
191236191236A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCompletedNo Results AvailableDepressive Disorder|Depressive Disorder, Major|DepressionDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00044681
191237191237Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: AC2993https://ClinicalTrials.gov/show/NCT00044668
191238191238Switching Medication to Treat SchizophreniaCompletedHas ResultsSchizophreniaDrug: Risperidone|Drug: Olanzapine|Drug: Ziprasidone|Drug: Quetiapine|Drug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT00044655
191239191239Lorazepam-Induced Toxicity in the AgedCompletedNo Results AvailableAnxiety Disorders|Generalized Anxiety DisorderDrug: Lorazepamhttps://ClinicalTrials.gov/show/NCT00044642
191240191240Combined Behavioral/Pharmacological Therapy for InsomniaCompletedNo Results AvailableSleep Initiation and Maintenance DisordersBehavioral: Cognitive-Behavioral Therapy for Insomnia|Drug: zolpidem tartrate (Ambien)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00044629
191241191241Relapse Prevention for Bipolar Type-II DisorderCompletedNo Results AvailableBipolar Disorder|DepressionDrug: Fluoxetine|Drug: Lithiumhttps://ClinicalTrials.gov/show/NCT00044616
191242191242Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.CompletedNo Results AvailablePregnancyhttps://ClinicalTrials.gov/show/NCT00044603
191243191243Parkinson's Diseases Susceptibility Genes and PesticidesRecruitingNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00044590
191244191244New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsCompletedNo Results AvailableHuman Immunodeficiency Virus I Infection|HIV InfectionDrug: abacavir/lamivudine|Drug: abacavir|Drug: lamivudine|Drug: tenofovirhttps://ClinicalTrials.gov/show/NCT00044577
191245191245Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell CarcinomaCompletedNo Results AvailableCarcinoma, Renal CellDrug: Bay 59-8862https://ClinicalTrials.gov/show/NCT00044564
191246191246Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphoma, Non-HodgkinDrug: Taxane (Cytotoxic, BAY59-8862)https://ClinicalTrials.gov/show/NCT00044551
191247191247Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer PatientsCompletedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: BAY59-8862 (Cytotoxic Taxane)https://ClinicalTrials.gov/show/NCT00044538
191248191248Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer PatientsCompletedNo Results AvailableBreast Neoplasms|Breast Cancer, MetastaticDrug: BAY59-8862 (Cytotoxic Taxane)https://ClinicalTrials.gov/show/NCT00044525
191249191249A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular CarcinomaCompletedHas ResultsCarcinoma, HepatocellularDrug: Sorafenib (Nexavar, BAY43-9006)https://ClinicalTrials.gov/show/NCT00044512
191250191250Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)CompletedNo Results AvailableLeukemia, Myelocytic, Acute|Myelodysplastic Syndromes|NeutropeniaDrug: Posaconazole oral suspensionhttps://ClinicalTrials.gov/show/NCT00044486

* Görseller ve İçerik tekif hakkına sahip olabilir